Financials in USD. Standardized financial statements.
A compact view of how Charming Medical Limited Class A Ordinary Shares turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Revenue? | $6.22M | $6.02M | $3.53M |
| Revenue Growth? | +3.4% | +70.4% | 0.0% |
| Cost of Revenue? | $2.04M | $2.10M | $2.04M |
| Gross Profit? | $4.18M | $3.91M | $1.49M |
| Gross Margin? | +67.2% | +65.1% | +42.3% |
| Operating Expenses? | $2.79M | $2.91M | $2.02M |
| Operating Income? | $1.39M | $1.01M | -$521,336 |
| EBITDA? | $1.72M | $1.42M | -$189,131 |
| Income Before Tax | $1.44M | $1.00M | -$420,468 |
| Income Tax Expense | $236,082 | $181,751 | -$84,863 |
| Net Income? | $1.20M | $777,811 | -$305,117 |
| EPS? | $0.07 | $0.05 | $-0.02 |
| Diluted EPS? | $0.07 | $0.05 | $-0.02 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality